Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Harriette Van Spall , Michael Andrew Borger Added: 8 months ago
ESC Congress 2025 - Dr Harriette Van Spall (McMaster University, Canada) sits down with Professor Michael Borger (University of Leipzig Heart Center, Germany), Co-Chair of the newly released 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.The new guidelines bring together the latest evidence and expert consensus on how to diagnose, evaluate, and treat patients with valvular… View more
Author(s): Roland R Tilz Added: 2 years ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125… View more
Author(s): Marten Falkenberg , Joakim Nordanstig Added: 8 months ago
ESC Congress 2025 - Paclitaxel-coated devices in critical limb threatening ischemia were not effective in preventing amputation, nor improving quality-of-life in intermittent claudication.Dr Mårten Falkenberg (Sahlgrenska University Hospital, Gothenburg, SE) and Prof Joakim Nordanstig (Sahlgrenska University Hospital, Gothenburg, SE) join us to discuss findings from the SWEDEPAD 1 and 2 parallel… View more
Author(s): David J Cohen Added: 6 months ago
TCT 2025 - The PREVUE-VALVE study finds an 8.2% prevalence of moderate or greater valvular heart disease amongst Americans age 65-85, increasing to 18.4% when participants with mild to moderate VHD were included.Dr David J. Cohen (Cardiovascular Research Foundation & St Francis Hospital, US) joins us to discuss findings from the PREVUE-VALVE study, examining age and sex-specific prevalence of… View more
Author(s): Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha Start date: Jun 30, 2026
Join us for New Horizons in Cardio Kidney Disease, a new one-day virtual educational event taking place on 30 June 2026. This programme is designed to address current challenges in cardio-kidney care through practical, cross-disciplinary education, with a focus on biomarker-guided risk assessment, optimisation of blood pressure and cardio-kidney therapies, and emerging multimodal strategies.The… View more